Clinical Trial Dosing Data AOD-9604 has been evaluated across multiple administration routes and dosing regimens
GHK-Cu occurs naturally in the human body and has extensive research for skin applications
For each eligible study, two authors (MM and AN) independently extracted data, which was then reviewed by a third author (JV) using a piloted spreadsheet, in accordance with Cochrane Collaboration guidelines ( Where relevant data were missing, attempts were made to contact corresponding authors
Discussion 1) The experiment performed by researchers Kwon and Park investigated the therapeutic potential of AOD9604, a synthetic peptide fragment of HGH, in a rabbit model of OA
PubMed: 15226334 GH Receptor Signaling and C-Peptide Fragment Role in AOD 9604 Mechanism of Action in vitro Liu X, Bersani M, Shen Y, et al
Used under supervision as part of a plan, AOD-9604 is explored to: Support fat metabolism Target stubborn belly fat A simple injection Hormone-friendly profile Physician-supervised Part of a broader plan A supervised, targeted fat-loss option Curious whether AOD-9604 fits your plan